References
- Lopez-Ovejero J. A., Weber M. A., Drayer J. I., Sealey J. E., Laragh J. H. Effects of indomethacin alone and during diuretics or beta-adrenoreceptors blockade therapy on blood pressure and the renin system in essential hypertension. Clin. Sci. Mol. Med. 1978; 55: 203s–205s
- Watkins J., Abbott E. C., Hensby C. N., et al. Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. Br. Med. J. 1980; 281: 702–705
- Wing L. M.H., Bune A. J.C, Chalmers J. P., Graham J. R., West M. J. The effects of indomethacin in treated hypertensive patients. Clin, and Exper. Pharmacol. & Physiol. 1981; 8: 537–541
- Salvetti A., Pedrinelli R., Alberici P., Magagna A., Abdel-Haq B. The influen ce of indomethacin and sulindac on some pharmacological actions of atenolol in hypertensive patients. Br. J. Clin. Pharmac. 1984; 17: 108s–111s
- Salvetti A., Arzilli F., Pedrinelli R., Beggi P., Motolese M. Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients. Eur. J. Clin. Pharmacol. 1982; 22: 197–201
- Mullane K. M., Moncada S. Prostacyclin mediates the potentiated hypotensive effect of bradykinin following captopril treatment. Eur. J. Pharmacol. 1980; 66: 355–365
- Swartz S. L., Williams G. H., Hollenberg N. K., et al Captopril induced changes in prostaglandin production. J. Clin. Invest. 1980; 65: 1257–1264
- Abe K., Ito T., Sato M., Haruyama T., Sato K., Omata K., Hiwatari M., Sakurai Y., Imai Y., Yoshinaga K. Role of prostaglandin in the antihypertensive mechanism of Captopril in low renin hypertension. Clin. Sci. 1980; 59: 141s–144s
- Salvetti A., Pedrinelli R., Magagna A., Ugenti P. Differential effects of selective and non-selective prostaglandin-synthesis inhibition on the pharmacological responses to captopril in patients with essential hypertension. Clin. Sci. 1982; 63: 261s–263s
- Salvetti A., Sassano P., Pedrinelli R., Arzilli F. The influence of indomethacin on pharmacological actions of Captopril in reno-vascular patients. Drugs Exptl. Clin. Res. 1980; 6: 541–551
- Davies R. O., Gomez H. J., Irvin J. D., Walker J. F. An overview of the clinical pharmacology of Enalapril. Br. J. Clin. Pharmac. 1984; 18: 215s–229s
- Shoback D. M., Williams G. H., Swartz S. L., Davies R. O., Hollenberg N. K. Time course and effect of sodium intake on vascular and hormonal responses to Enalapril (MK 421) in normal subjects. J. Cardiovasc. Pharmacol. 1983; 5: 1010–1018
- Golub M., Eggena P., Barrett J., Sambhi M. Cyclooxygenase inhibitors do not influence the blood pressure response to the converting enzyme inhibitor Enalapril. In 10th Scientific Meeting of the International Society of Hypertension, InterlakenSwitzerland, June 17–21, 1984, Abs 398
- Oparil S., Horton R., Wilkins L. H., Irvin J., Hammett D. K., Dustan H. P. Antihypertensive effect of Enalapril (MK 421) in low renin essential hypertension: role of vasodilator prostaglandins. Clin. Res. 1983; 31(2)538a